Evidence map›Paper›PMID 34110601›Full record

ArticleEndocrine2021

Postoperatively determined high-risk histopathologic features in papillary thyroid carcinoma initially eligible for thyroid lobectomy: a game changer.

Sohail Bakkar, Khaled Al-Omar, Gianluca Donatini, Qusai Aljarrah, Theodosios S Papavramidis, Gabriele Materazzi, Paolo Miccoli

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Sohail BakkarDepartment of General and Specialized Surgery, Faculty of Medicine, the Hashemite University, Zarqa, 13133, Jordan. sohail.bakkar@gmail.com.ORCID http://orcid.org/0000-0001-8479-5901
Khaled Al-OmarDepartment of General and Specialized Surgery, Faculty of Medicine, the Hashemite University, Zarqa, 13133, Jordan.
Gianluca DonatiniDepartment of General and Endocrine Surgery, University of Poitiers, CHU Poitiers, Poitiers, France.
Qusai AljarrahDepartment of Surgery, Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
Theodosios S Papavramidis1st Propaedeutic Surgical Department, University Hospital of Thessaloniki AHEPA, Aristotle University of Thessaloniki (AUTH), Thessaloniki, 5462, Greece.
Gabriele MaterazziDepartment of Surgical, Medical, Pathology, and Critical Care, The University of Pisa, Pisa, 56124, Italy.
Paolo MiccoliDepartment of Surgical, Medical, Pathology, and Critical Care, The University of Pisa, Pisa, 56124, Italy.
Hashemite University · JOUniversity of Pisa · ITAristotle University of Thessaloniki · GRJordan University of Science and Technology · JOUniversité de Poitiers · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRecent clinical practice guidelines consider thyroid lobectomy a viable alternative for low-risk papillary thyroid carcinoma PTC measuring 1-4 cm in size. We aimed to assess the likelihood of finding postoperatively determined high-risk histopathologic features that would lead to the recommendation of completion thyroidectomy.

methodsA retrospective review of patients who underwent total thyroidectomy for PTC measuring 1-4 cm in size between Jan 2012 and Jan 2018 was conducted. Patients with pre-operative high-risk characteristics were excluded: history of radiation exposure, positive family history, clinically suspicious cervical lymphadenopathy, and gross extrathyroidal extension (ETE). A hypothetical group of 245 patients remained eligible for lobectomy. The pathology specimens from the cancer-containing lobes were evaluated for high-risk features: aggressive histology, capsular and/or vascular invasion, microscopic ETE, and multifocality. A subgroup analysis was performed with 2 cm being the cut-off size.

resultsThe average age was 39 years with 73% being females. Mean cancer size was 16 mm. Evaluation of the cancer-containing lobe for high-risk features revealed: aggressive histology (33%), ETE (12%), capsular invasion (33%), vascular invasion (17%), and ipsilateral multifocality (30%). The cumulative risk of having ≥1 high-risk feature mandating completion thyroidectomy was 59%. The risk was considerably higher for lesions ≤2 cm compared to larger lesions (64% vs.48%; p = 0.049; RR = 1.3).

conclusionsA considerable proportion of patients initially eligible for lobectomy have high-risk features that only become evident at pathology. Therefore, a comprehensive approach is advocated to determine the extent of surgery for PTC incorporating patient preferences regarding risks and benefits.

Indexed as

Carcinoma, PapillaryThyroid NeoplasmsAdultFemaleHumansMaleNeoplasm Recurrence, LocalRetrospective StudiesThyroid Cancer, PapillaryThyroidectomyExtent of surgeryLow-riskPapillary thyroid carcinomaThyroid lobectomyTotal thyroidectomy

Identifiers

PMID34110601
OpenAlexW3153249461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.